Loading...
Market
FDA's actions on similar drugs post-Pfizer Zantac settlement
5
Resolution / Starting Odds
No action • 33%
Warning issued • 33%
Drug recalls • 33%
FDA announcements and official press releases
Story
Pfizer to Pay $250 Million to Settle Over 10,000 Zantac Cancer Lawsuits
May 16, 2024, 04:55 AM
Pfizer has agreed to offer up to $250 million to settle more than 10,000 lawsuits in the United States over cancer risks associated with its now-discontinued heartburn drug Zantac. The Financial Times reported this settlement on Thursday.
View original story
Similar markets
GSK and Pfizer found liable • 33%
GSK and Pfizer not found liable • 33%
Case settled out of court • 34%
Pharmaceutical companies win • 33%
Plaintiff wins • 33%
Settlement • 34%
GSK wins • 33%
GSK loses • 33%
Settlement reached • 33%
No further significant lawsuits • 33%
Few minor lawsuits • 33%
Significant new lawsuits • 34%
Less than 10,000 • 33%
10,000 - 50,000 • 34%
More than 50,000 • 33%
No further action • 33%
Additional warnings issued • 33%
Restriction on use broadened • 33%
Further research commissioned • 25%
Public awareness campaign launched • 25%
No significant action taken • 25%
Immediate regulation or restrictions imposed • 25%